{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:42:26Z","timestamp":1794937346907,"version":"4.9.1"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:p>Secretory carcinoma is a special-type breast carcinoma underpinned by a recurrent t(12;15)(p13;q25) translocation resulting in <jats:italic toggle=\"yes\">ETV6-NTRK3<\/jats:italic> gene fusion. Immunohistochemistry (IHC) using a pan-TRK antibody has been recently shown to help identify <jats:italic toggle=\"yes\">NTRK<\/jats:italic> rearrangements in other tumor types. The purpose of this study was to assess the diagnostic utility of pan-TRK IHC in secretory carcinoma of the breast. Pan-TRK IHC was performed using a rabbit monoclonal antibody on whole sections of 24 breast secretory carcinomas and tissue microarray sections of other breast carcinoma types (n=203) and histologic mimics (n=15). Cases were assessed for staining intensity and localization. The 24 patients with secretory carcinoma had a median age of 44 years and a median tumor size of 1.0\u2009cm. <jats:italic toggle=\"yes\">ETV6<\/jats:italic> fluorescence in situ hybridization was positive in all cases tested (n=20). Twenty-three cases (95.8%) showed staining with pan-TRK, which was exclusively nuclear in 19, primarily nuclear with weak cytoplasmic staining in 3, and primarily cytoplasmic with focal nuclear staining in 1. The nuclear staining was diffuse in 17 and at least focally strong in 17. The only pan-TRK negative case was a core biopsy with limited tumor. Among the 203 nonsecretory carcinomas, 21 (10.3%) showed focal, weak nuclear staining in &lt;5% of tumor cells and 1 (0.5%) showed focal membranous staining. All histologic mimics were negative. In conclusion, diffuse and\/or at least focally strong nuclear pan-TRK staining is a sensitive and specific marker for secretory carcinoma of the breast.<\/jats:p>","DOI":"10.1097\/pas.0000000000001366","type":"journal-article","created":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T01:45:53Z","timestamp":1567993553000},"page":"1693-1700","source":"Crossref","is-referenced-by-count":66,"title":["Pan-TRK Immunohistochemistry"],"prefix":"10.1097","volume":"43","author":[{"given":"Beth T.","family":"Harrison","sequence":"first","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Fowler","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregor","family":"Krings","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunn-Yi","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of California San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory R.","family":"Bean","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford University School of Medicine, Stanford, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Vincent-Salomon","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Fuhrmann","sequence":"additional","affiliation":[{"name":"Department of Pathology, Institut Curie, Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra E.","family":"Barnick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Memorial Hospital West, Pembroke Pines, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beiyun","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, Mayo Clinic and Foundation, Rochester, MN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth M.","family":"Hosfield","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaiser Permanente San Francisco Medical Center, San Francisco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L.","family":"Hornick","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Harvard Medical School"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J.","family":"Schnitt","sequence":"additional","affiliation":[{"name":"Department of Pathology, Brigham and Women\u2019s Hospital"},{"name":"Harvard Medical School"},{"name":"Dana-Farber Cancer Institute, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,9,6]]},"reference":[{"key":"R2-20230922","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.1966.03100050096033","article-title":"Breast carcinoma in children","volume":"195","author":"McDivitt","year":"1966","journal-title":"JAMA"},{"key":"R3-20230922","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1477-7819-3-35","article-title":"Secretory carcinoma of the breast containing the ETV6-NTRK3 fusion gene in a male: case report and review of the literature","volume":"3","author":"Arce","year":"2005","journal-title":"World J Surg Oncol"},{"key":"R4-20230922","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/1097-0142(19800501)45:9<2404::AID-CNCR2820450928>3.0.CO;2-8","article-title":"Secretory carcinoma of the breast","volume":"45","author":"Tavassoli","year":"1980","journal-title":"Cancer"},{"key":"R5-20230922","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0046-8177(03)00423-4","article-title":"Secretory carcinoma of the breast: a distinct variant of invasive ductal carcinoma assessed by comparative genomic hybridization and immunohistochemistry","volume":"34","author":"Diallo","year":"2003","journal-title":"Hum Pathol"},{"key":"R6-20230922","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/modpathol.2011.190","article-title":"Secretory breast carcinoma: a clinicopathological and immunophenotypic study of 15 cases with a review of the literature","volume":"25","author":"Li","year":"2012","journal-title":"Mod Pathol"},{"key":"R7-20230922","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1097\/PAS.0000000000000487","article-title":"Secretory breast carcinoma: a histopathologic and genomic spectrum characterized by a joint specific ETV6-NTRK3 gene fusion","volume":"39","author":"Del Castillo","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"R8-20230922","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/modpathol.2017.32","article-title":"Genomic profiling of breast secretory carcinomas reveals distinct genetics from other breast cancers and similarity to mammary analog secretory carcinomas","volume":"30","author":"Krings","year":"2017","journal-title":"Mod Pathol"},{"key":"R9-20230922","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/modpathol.2008.184","article-title":"Secretory breast carcinomas with ETV6-NTRK3 fusion gene belong to the basal-like carcinoma spectrum","volume":"22","author":"Lae","year":"2009","journal-title":"Mod Pathol"},{"key":"R10-20230922","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/his.13879","article-title":"Secretory carcinoma of the breast: clinicopathologic profile of 14 cases emphasizing distant metastatic potential","volume":"75","author":"Hoda","year":"2019","journal-title":"Histopathology"},{"key":"R11-20230922","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.breast.2012.02.013","article-title":"Secretory carcinoma of the breast: results from the survival, epidemiology and end results database","volume":"21","author":"Horowitz","year":"2012","journal-title":"Breast"},{"key":"R12-20230922","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S1535-6108(02)00180-0","article-title":"Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma","volume":"2","author":"Tognon","year":"2002","journal-title":"Cancer Cell"},{"key":"R13-20230922","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/gcc.20028","article-title":"A fluorescence in situ hybridization study of ETV6-NTRK3 fusion gene in secretory breast carcinoma","volume":"40","author":"Makretsov","year":"2004","journal-title":"Genes Chromosomes Cancer"},{"key":"R14-20230922","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","article-title":"NTRK fusion-positive cancers and TRK inhibitor therapy","volume":"15","author":"Cocco","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"key":"R15-20230922","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3390\/diagnostics6010004","article-title":"Economic analysis of alternative strategies for detection of alk rearrangements in non small cell lung cancer","volume":"6","author":"Doshi","year":"2016","journal-title":"Diagnostics (Basel)"},{"key":"R16-20230922","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jclinpath-2018-205679","article-title":"Testing algorithm for identification of patients with TRK fusion cancer","volume":"72","author":"Penault-Llorca","year":"2019","journal-title":"J Clin Pathol"},{"key":"R17-20230922","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1097\/PAS.0000000000000911","article-title":"Pan-Trk immunohistochemistry is an efficient and reliable screen for the detection of NTRK fusions","volume":"41","author":"Hechtman","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R18-20230922","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41379-018-0118-3","article-title":"Molecular characterization of cancers with NTRK gene fusions","volume":"32","author":"Gatalica","year":"2019","journal-title":"Mod Pathol"},{"key":"R19-20230922","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13666","article-title":"Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics","volume":"73","author":"Hung","year":"2018","journal-title":"Histopathology"},{"key":"R20-20230922","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/his.13845","article-title":"Immunohistochemistry using a Pan-TRK antibody distinguishes secretory carcinoma of salivary gland from acinic cell carcinoma","volume":"75","author":"Hung","year":"2019","journal-title":"Histopathology"},{"key":"R21-20230922","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","article-title":"Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors","volume":"42","author":"Rudzinski","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"R22-20230922","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1056\/NEJMoa1714448","article-title":"Efficacy of larotrectinib in TRK fusion-positive cancers in adults and children","volume":"378","author":"Drilon","year":"2018","journal-title":"N Engl J Med"},{"key":"R23-20230922","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1158\/2159-8290.CD-16-1237","article-title":"Safety and antitumor activity of the multitargeted Pan-TRK, ROS1, and ALK inhibitor entrectinib: combined results from two phase I trials (ALKA-372-001 and STARTRK-1)","volume":"7","author":"Drilon","year":"2017","journal-title":"Cancer Discov"},{"key":"R24-20230922","doi-asserted-by":"crossref","first-page":"e000023","DOI":"10.1136\/esmoopen-2015-000023","article-title":"NTRK gene fusions as novel targets of cancer therapy across multiple tumour types","volume":"1","author":"Amatu","year":"2016","journal-title":"ESMO Open"},{"key":"R25-20230922","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0304-3835(01)00530-4","article-title":"Trk receptor tyrosine kinases: a bridge between cancer and neural development","volume":"169","author":"Nakagawara","year":"2001","journal-title":"Cancer Lett"},{"key":"R26-20230922","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.cancergencyto.2006.01.006","article-title":"Identification of the nuclear localization motif in the ETV6 (TEL) protein","volume":"167","author":"Park","year":"2006","journal-title":"Cancer Genet Cytogenet"},{"key":"R27-20230922","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.humpath.2018.08.011","article-title":"Novel gene fusions in secretory carcinoma of the salivary glands: enlarging the ETV6 family","volume":"83","author":"Guilmette","year":"2019","journal-title":"Hum Pathol"},{"key":"R28-20230922","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/pin.12766","article-title":"Non-secretory breast carcinomas lack NTRK rearrangements and TRK protein expression","volume":"69","author":"Remou\u00e9","year":"2019","journal-title":"Pathol Int"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T22:51:45Z","timestamp":1695423105000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001366"}},"subtitle":["A Useful Diagnostic Adjunct For Secretory Carcinoma of the Breast"],"short-title":[],"issued":{"date-parts":[[2019,9,6]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001366","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9,6]]}}}